Aortic aneurysm in Behcet’s disease, endovascular management options

Abstract

This study aims to review contemporary lines of endovasular management of Aortic aneurysm in bechet’s disease illustrating the pros and cons of each treatment modality. This is a retrospective cohort study of all consecutive Aortic aneurysms in patients diagnosed bechet’s disease treated between 2018-2021. The aim of this study is to evaluate efficacy &outcome of endovascular stent graft implantation for the treatment of Aortic aneurysm in Bechet’s disease. From feb 2018 to august 2021, 11 Aortic aneurysms were diagnosed in 10 patients with Bechet’s disease. All patients were male. The patients ranged in age from 33 to 66 years (median ,41 years). There were three infrarenal abdominal aortic aneurysm, two supra celiac aneurysm, three descending thoracic, one Aortic arch aneurysm, and one patient had both pararenal &descending thoracic aneurysm. All patients received immunosuppressive therapy before intervention to induce remission. After hospital discharge, all patients were followed up regularly at 3 months intervals. The mean duration of follow-up was 22.6 months (range ,1-39 months). A straight tube graft was implanted in nine patients and a bifurcated graft in one patient. Two stage procedures (debranching before endovascular therapy) were performed in three patients.